Farmacia Hospitalaria y Farmacogenómica

Gimenez-Manzorro, A; Romero-Jimenez, RM; Calleja-Hernandez, MA; Pla-Mestre, R; Munoz-Calero, A; Sanjurjo-Saez, M.

Effectiveness of an electronic tool for medication reconciliation in a general surgery department

International Journal of Clinical Pharmacy. 2015; 37(1): 159-167 Nº de citas: 13 [doi:10.1007/s11096-014-0057-0]

Marzal-Alfaro MB; Manrique-Rodríguez S; Alcaraz Romero A; García San Prudencio M; Fernández-Llamazares CM.

Infección sistémica por citomegalovirus: influencia del tratamiento con foscarnet en los niveles plasmáticos de calcio y magnesio.

ANALES DE PEDIATRIA. 2015; 82(1): 4 Nº de citas: 1 [doi:10.1016/j.anpedi.2014.03.021]

Rodriguez González, Carmen G.; Martín Barbero, M. Luisa; Herranz Alonso, Ana; DURANGO, M.; Sanjurjo Sáez, Maria.

Use of failure mode, effect and criticality analysis to improve safety in the medication administration process

JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2015; 21(4): 549-559

de Lorenzo-Pinto, A; Garcia-Sanchez, R; Izquierdo, CP; Duran-Garcia, ME; Castuera-Gil, AI; Andueza-Lillo, JA; Sanjurjo-Saez, M.

Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2015; 69(1): 81-86 Nº de citas: 2 [doi:10.1111/ijcp.12461]

Requena, T; Ais, A; Yebenes, M; Casado, MA; Rueda, M.

Persistence with oral antiviral therapy in previously untreated patients with chronic hepatitis B in Spain: the EUPTHEA study

European Journal of Hospital Pharmacy-Science and Practice. 2014; 21(6): 344-349 [doi:10.1136/ejhpharm-2014-000452]

Escudero-Vilaplana V; Osorio Prendes S; Sanjurjo Sáez M.

Posible exantema pruriginoso secundario a lenalidomida.

FARMACIA HOSPITALARIA. 2014; 38(6): 495-496 Nº de citas: 1 [doi:10.7399/fh.2014.38.6.8176]

Ribed, A; Romero-Jimenez, RM; Cuerda-Compes, C; Higuera-Pulgar, I; Carrascal-Fabian, ML; Escudero-Vilaplana, V; Arranz-Arija, JA; Garcia-Peris, P; Sanjurjo-Saez, M.

NUTRITIONAL ASSESSMENT AND QUALITY OF LIFE OF ONCOLOGY OUTPATIENTS INITIATING TREATMENT WITH TYROSINE-KINASE INHIBITORS

Nutricion Hospitalaria. 2014; 30(5): 1092-1100 Nº de citas: 3 [doi:10.3305/nh.2014.30.5.7761]

Arango, C; Giraldez, M; Merchan-Naranjo, J; Baeza, I; Castro-Fornieles, J; Alda, JA; Martinez-Cantarero, C; Moreno, C; de Andres, P; Cuerda, C; de la Serna, E; Correll, CU; Fraguas, D; Parellada, M.

Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naive Patients

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2014; 53(11): 1179-1190 Nº de citas: 75 [doi:10.1016/j.jaac.2014.08.009]

Cortejoso L; Gómez-Antúnez M; Muiño-Míguez A; Durán-García ME; Sanjurjo-Sáez M.

Acyclovir and hyponatremia: a case report.

AMERICAN JOURNAL OF THERAPEUTICS. 2014; 21(5): 3 Nº de citas: 4 [doi:10.1097/MJT.0b013e3182691aca]

Cortejoso L; García-Lledó J; Giménez-Manzorro A; Salcedo-Plaza M; Matilla-Peña A; Sanjurjo-Sáez M.

Antiangiogenic drugs and cardiogenic shock: a case report.

AMERICAN JOURNAL OF THERAPEUTICS. 2014; 21(5): 5 Nº de citas: 1 [doi:10.1097/MJT.0b013e31826a94fc]

García-Lledó J; Cortejoso L; Tenorio Núñez M; Giménez-Manzorro A; Matilla-Peña A; Salcedo-Plaza M; Sanjurjo-Sáez M.

Cardiovascular toxicity and sorafenib: a case report.

AMERICAN JOURNAL OF THERAPEUTICS. 2014; 21(5): 70 Nº de citas: 3 [doi:10.1097/MJT.0b013e318274df35]

Higuera, I; Garcia-Peris, P; Camblor, M; Breton, I; Velasco, C; Romero, R; Frias, L; Cuerda, C.

Outcomes of a general hospital-based Home Parenteral Nutrition (HPN) program; report of our experience from a 26-year period

Nutricion Hospitalaria. 2014; 30(2): 359-365 Nº de citas: 27 [doi:10.3305/nh.2014.30.2.7592]

de Lorenzo-Pinto, A; Bueno, H; Herranz-Alonso, A; Elizaga-Corrales, J; Perez-Sanz, C; Cuellar-Basterrechea, B; Fernandez-Aviles, F; Sanjurjo-Saez, M.

Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

International Journal of Clinical Pharmacy. 2014; 36(4): 821-826 Nº de citas: 2 [doi:10.1007/s11096-014-9972-3]

Marquinez-Alonso, I; Escudero-Vilaplana, V; Pernia, S; Bieler, CB; Fernandez-Llamazares, CM; Sanjurjo-Saez, M.

The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2014; 39(4): 376-382 Nº de citas: 4 [doi:10.1111/jcpt.12156]

Solana, MJ; Colom, H; Lopez-Herce, J; Urbano, J; Gonzalez, R; Lopez, J; Manzanares, C; Carrillo, A.

Population Pharmacokinetics of Omeprazole in Critically Ill Pediatric Patients

THERAPEUTIC DRUG MONITORING. 2014; 36(4): 519-527 Nº de citas: 4

Cortejoso, L.; García, MI.; García Alfonso, P.; Grávalos, C.; Robles, L.; González Haba, E.; SANJURJO SAEZ, MARÍA; López Fernández, LA..

[Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2014; 38(4): 283-373

Valerio, M; Rodriguez-Gonzalez, CG; Munoz, P; Caliz, B; Sanjurjo, M; Bouza, E.

Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2014; 69(7): 1993-1999 Nº de citas: 115 [doi:10.1093/jac/dku053]

Ribed, A; Escudero-Vilaplana, V; Gonzalez-Haba, E; Sanjurjo, M.

Increased INR after gefitinib and acenocoumarol co-administration

European Review for Medical and Pharmacological Sciences. 2014; 18(12): 1720-1722 Nº de citas: 2